ReShape Lifesciences CEO Gladney to resign | Personnel Moves – January 29, 2019

January 29, 2019 By Fink Densford

ReShape Lifesciences (NSDQ:RSLS) said yesterday that its prez & CEO Dan Gladney will resign from his positions with the company, effective March 31.

Gladney will remain with the company as board chair, San Clemente, Calif.-based ReShape Lifesciences said.

The company’s board of directors said they will immediately begin to look for a replacement, according to an SEC filing.

AliveCor CEO Gundotra steps away

AliveCor CEO Vic Gundotra is stepping away from his position at the head of the company, according to a recent CNBC report.

Gundotra, a former senior VP with Google, said it will remain active on AliveCor’s board as the Mountain View, Calif.-based company searches for an internal replacement, according to the report.

“I’m leaving the company in a position of strength,” Gundotra said, according to CNBC.

“We all love Vic. We sold hundreds of thousands of devices and continue to gain more traction, so all I can say is he did a great job,” founder & chief medical officer David Albert said, according to the report.

AliveCor has not yet officially commented on the leadership change.

New Zealand-based Adherium (ASK:ADR) has significantly downsized its workforce, including the exit of CEO Erik Anderson and CFO David Allinson, according to a New Zealand Herald report.

Former finance and business services VP Rob Turnbull will take up the position of GM and oversee the reorganization of the company, according to the report.

Alongside the exit of the execs, the company will also be slashing its general workforce by 80%, according to the NZ Herald.

“While the reduction in workforce is very regrettable, our focus remains to develop the company as has originally been planned. In meeting our customers’ commercial requirements, we will continue to develop leading solutions in our space, and in this our R&D activity will continue to be run from our Auckland office,” Turnbull told the Herald.

Turnbull said that the company would further explain its reorganization plans next month, according to the report.

Functional Neuromodulation said this week said that it tapped current prez & COO Todd Langevin to succeed existing CEO Vincent Owens, effective January 25.

Prior to joining Functional Neuromodulation, Langevin held senior leadership roles at Medtronic and CVRx, including acting as VP and GM of Medtronic’s DBS movement disorders business and as the company’s neuromodulation European business director.

“Todd has been instrumental in leading the company through the ADvance I study, CE Mark approval, and IDE approval of the ADvance II pivotal study of DBS-f. FNM’s investors, employees and I have great confidence in Todd’s leadership and we look forward to beginning enrollment in ADvance II,” Owens said in a press release.

Read more

AxoGen appointes Sandberg as CCO

AxoGen said last week that it appointed Eric Sandberg as its new chief commercial officer, replacing Jon Gingrich who is set to resign effective February 15.

Prior to his time with AxoGen, Sandberg held leadership roles at various medtech firms including Guidant, CardioDx, Tangent Medical and Boston Scientific, the Alachua, Fla.-based company said.

“We are excited to welcome Eric to our executive team; his breadth of commercialization experience and proven track record of execution will be invaluable as we introduce new applications and launch new products that expand and enhance our platform for nerve repair. Eric’s executive leadership will be instrumental as AxoGen continues to transform peripheral nerve repair and create a new standard of care,” prez & CEO Karen Zaderej said in a press release.

“AxoGen has an outstanding culture of innovation and excellence, and I look forward to building upon the company’s strong foundation. AxoGen has a tremendous opportunity to improve outcomes and quality of life for patients suffering the debilitating effects of peripheral nerve damage, across a growing range of applications. I am thrilled to join the Company at this critical and exciting time, as we pursue and develop these markets,” Sandberg said in a prepared statement.

Read more

CVRx CEO Nadim Yared suggests steps toward improving diversity and equality
In this week’s episode of DeviceTalks Weekly, we follow up with last week’s guest, Nadim Yared, CEO of CVRx, to catch up on how the medtech executive is managing during the pandemic. Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide… […]
Ogura Industrial touts holding brakes for robotic and medical equipment
As automation continues to accelerate, there’s a growing need to hold equipment in place in the case of a power failure — or to provide positioning, according to Ogura Industrial, maker of six different styles of holding brakes. With roughly 120 standard models, key features of Ogura Industrial’s holding brake families include brake diameters down… […]
What kinds of COVID-19 tests are out there?
Months into the pandemic, the FDA continues to grant emergency use approval (EUA) to new tests to detect the virus that causes COVID-19 and the antibodies that indicate a person has had it. To date, the FDA has granted EUAs for 171 tests —142 molecular tests, 27 antibody tests, and 2 antigen tests. Given the ever-changing… […]
FDA plans to resume onsite inspections later this month
FDA has a goal of restarting on-site inspections during the week of July 20 — four months after it temporarily halted them — though there will be changes due to the COVID-19 pandemic. The agency today said that it will pre-announce inspections to FDA-regulated businesses. Said FDA: “This will help assure the safety of the… […]
Formlabs announces new biocompatible, medical-grade resins
Formlabs, the Somerville, Mass.–based maker of 3D printers, recently announced six new materials across its Form 3, Form 3B, and Form 2 SLA 3D printers — including two new biocompatible, medical-grade resins. The new material families and resins are meant to provide more options for designers and engineers in fields including: Healthcare — with a… […]
Magnolia Medical launches Steripath Gen2 with integrated syringe
Magnolia Medical this week said it launched its Steripath Gen2 Initial Specimen Diversion Device with an integrated syringe. The device is designed for reducing blood culture contamination in “hard stick” patients and syringe collection protocols. Steripath Gen2 features an integrated syringe that addresses difficult intravenous access. It offers precise control to carefully collect blood samples.… […]
How Frankenstein sparked Earl Bakken’s love of medical devices
When the late Medtronic founder Earl Bakken first watched the classic horror movie “Frankenstein” in the 1930s, it did more than just scare: It inspired. “What intrigued me the most as I sat through the movie again and again, was the creative spark of Dr. Frankenstein’s electricity,” Bakken said in his 1990 autobiography “One Man’s… […]
Boston researchers have created a potential N95 mask alternative
Brigham & Women’s Hospital says it is developing a new, sustainable alternative to N95 respirator masks that are in demand during the COVID-19 pandemic. A team of bioengineers and clinical experts at the Boston-based hospital and the Massachusetts Institute of Technology (MIT) are working on the “injection molded autoclavable, scalable, conformable” iMASC system for providing… […]
MIT researchers think they’ve found a way to get more particles through a syringe
Researchers at the Massachusetts Institute of Technology (MIT) are touting a computational model that could prevent microparticle clogging during injections. Microparticles, which are about the size of a grain of sand, can be difficult to inject if they get clogged in a typical syringe. The research team at MIT developed this new model that determines… […]
Fotofab adds direct-imaging machine for chemical etching
Fotofab announced this week that it has acquired a new Chime Ball Technologies direct-imaging (DI) machine from Technica, USA to optimize its chemical etching process and provide a more advanced level of precision and speed for thin metal parts. The DI machine has CBT’s patented finger-print technology with LED lighting that enables Fotofab to directly… […]
Could this heated air filter help fight COVID-19?
University of Houston researchers and medical real estate development firm Medistar claim that they’ve designed an air filter that can catch and instantly kill the virus that causes COVID-19. Galveston National Laboratory tests on the filter found it killed 99.8% of SARS-CoV-2 virus in a single pass — as well as 99.9% of anthrax spores,… […]

ReShape Lifesciences CEO Gladney to resign | Personnel Moves – January 29, 2019

In case you missed it

From Medical Design & Outsourcing

MASSDEVICE MEDICAL NETWORK

MASSDEVICE